Professional Documents
Culture Documents
BACTERIAL
• Chorioretinitis
• Retinochoroiditis
• Retinitis
• Neuroretinitis
POSTERIOR UVEITIS- ETIOLOGY
VIRAL HERPESVIRIDAE-HSV, VZV, CMV, EBV
RUBELLA
LYMPHOCYTIC CHORIOMENINGITIS VIRUS
RUBEOLA
WEST NILE VIRUS
OTHERS
FUNGAL HISTOPLASMOSIS
CANDIDIASIS
ASPERGILLUS
PROTOZOAL TOXOPLASMOSIS
HELMINTHIC TOXOCARIASIS
CYSTICERCOSIS
DIFFUSE UNILATERAL SUBACUTE NEURORETINITS
ONCHOCERCIASIS
BACTERIAL SYPHILIS
TUBERCULOSIS
BARTONELLA (CAT-SCRATCH DISEASE)
BORRELIA
Pathogenesis
• Choroid & outer retinal layers involved.
• Granulomatous (lymphocytes, plasma cells)
• Non- granulomatous (leucocytes, macrophages, epitheloid cells)
• Early stages- fluid passes – retina cloudy
• Exudates pass- vitreous opacities
• Later stages- leucocytes in vitreous & retina
• Exudates organize- fibrosis- choroid & retina fuse
SYMPTOMS
• Painless loss of vision
• Retinitis or choroiditis affecting macular function or complications like CME,
ERM, retinal ischemia, CNV, refractive error, opacities in visual axis
• Scotoma (central or peripheral)
• Floaters
• Photopsias
• Metamorphopsia
• Nyctalopia
SIGNS
RETINITIS INFLAMMATORY INFILTARATES
RPE HYPERTROPHY OR ATROPHY
PRE- OR SUBRETINAL FIBROSIS
RETINAL DETACHMENT
(EXUDATIVE,TRACTIONAL,RHEGMATOGENOUS)
NEOVASCULARIZATION
o Rarely found
o Believed to be an immune
mediated hypersensitivity reaction
in the presence of bacteria in
choroid or RPE.
o Vasculitis – staining and leakage from vessel wall. Look for cnp also
2) Indocyanine green angiography
o To detect subclinical choroidal lesions in presumed IOTB
o Lesions are hypo in early and intermediate phases, may become iso in late phase.
o ICG changes are reversible and maybe used to monitor response to therapy
3) OCT
o Can detect retinal pathologies such as subretinal neovascular membrane and CME
4) USG / UBM
o can help differentiate granulomas (low internal reflectivity) from retinoblastoma/
melanoma etc
o Helps studying pars plana region – granulomas, cyclitic membrane
Pathology
• Direct evidence of the presence of bacilli in ocular tissue would be ideal for establishing a
diagnosis
a) Clinical indicators
b) Corroborative evidence
c) Direct evidence
Corroborative evidence
a) PPD / Montoux test
o <5 mm is negative
o 5-10mm – considered positive in HIV patients, those with healed lesion on chest xray and those
in close contact with infectious case
Vaccination induced reaction wane with time and unlikely to persist for more than 10 years
b) Chest radiography and CT
c) Serodiagnosis
b) Culture
o LJ medium shows growth in 6-8 weeks
o Prolonged and cumbersome process
o Low yield from intraocular fluid
c) PCR
o Amplify bacteria several fold
o Thus can be performed on a small sample
• For diagnosis LTBI has to be demonstrated as very few patients have
ocular involvement with active TB
• LTBI indirectly detected by demonstrating the hypersensitivity
generated.
inaccurate as degree of hypersensitivity can vary unpredictably.
Endemic area majority will have LTBI
TST
• False positive in BCG, NTB, improper technique
• False negative -
- window period (within 8-10 weeks of exposure)
-Immunosuppressed /sarcoidosis
-Recent viral infections/live virus vaccination (measles)
-Overwhelming infection-Disseminated TB
-Malnutrition/old age
-Incorrect technique
• Anergic in endemic areas-may suggest sarcoid uveitis
• Montoux drawbacks
1. Subjective
2. 2 step procedure
3. High False positives and False negatives
4. Low specificity-Esp in areas with high BCG coverage and NTM exposure (endemic)
5. Mod sensitivity- but low in pts with depressed immunity or overwhelming
infection
• Advantages if IGRA
1. One step procedure
2. Less subjective
3. Faster results
4. Higher specificity
5. High sensitivity for active disease
6. Can be done in BCG vaccinated pts
7. Malnourished/immunocompromised
Suggested guidelines for diagnosis of iotb
CONFIRMED CASE
• clinical sign + ocular investigation
PRESUMED CASE
• clinical sign + systemic inv
Or
• positive therapeutic trial + exclusion of
other causes
Treatment
A) Medical management
o 4 drug regimen in intensive phase followed by 2 or 3 drug regimen in
continuation phase
o Duration recommended by various authors is 9-12 months,
depending on clinical response which is usually evident by 4-6 weeks.
o System steroids 0.5-1 mg/kg/day also started simultaneously, for 6-8
weeks
o MDR cases- additional agents like rifabutin, fluoroquinolones,
linezolid are added and treatment lasts for 18-24 months
o Ethambutol toxicity should be looked for
o Usually if dose is >15mg/kg/day for 3-6 months
o Toxicity is dose related
o Toxicity due to decreased ATPase activity and mitochondrial
homeostasis
o High dose patients should be evaluted monthly
Syphilis
• Spirochaete Treponema pallidum
• Incidence has ↓ with accurate diagnostic techniques & penicillin
therapy
Syphilis though uncommon in HIV, pursues a more aggressive course & respond less well to
conventional therapy - test all patients with ocular syphilis for HIV and vice-versa.
Clinical features
• Vitritis • Nectrotizing retinitis
• Neuroretinitis
• Untreated secondary optic • Serous retinal detachment
atrophy + replacement of retinal
vessels by white strands.
• Clinical diagnosis
• Typical history of prodromal symptoms, lymphadenopathy, and cat
exposure helps strengthen the diagnosis, especially when presenting in
young adults or children.
• It more commonly presents in the younger ages in the late summer and
fall months.
• Diagnostic procedures
• Visual field testing sometimes shows cecocentral scotoma.
• Fluorescein angiography often shows optic nerve leakage or can show
artery/venous occlusions.
• Optical coherence tomography (OCT) can display the degree of subretinal
fluid, retinal thickening, and exudates.
• OCT angiography may be able to show neovascularization within an area of
chorioretinitis.
• Biopsy: classically shows granulomatous inflammation.
• Warthin-Starry silver stain on biopsy can identify the bacteria.
• Culture: B. henselae is a fastidious, slow-growing, gram-negative rod that
requires specific culture techniques for tissue or blood such as up to 1
month incubation period, enriched agar with 5% CO2 at 32-35 degrees
Celsius.
Medical therapy